Identification of semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA differential display

Journal of Surgical Oncology

Volumn 72, Issue 1, 1999, Pages 18-23

  Martín Satué, Mireia ^a   Blanco, Jerónimo ^a,b,c  

^a Institut de Recerca Oncologica   (Spain)

^b CSIC   (Spain)

^c HOSPITAL DURAN I REYNALS   (Spain)

Author keywords

6.6.5 mRNA sequence; Differential display PCR; H sema E; HAL 24Luc cells; HAL 8Luc cells; MS3 mRNA sequence; Nuclear RNA binding protein; Semaphorin E

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; SEMAPHORIN;

ARTICLE; CANCER INVASION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; METASTASIS POTENTIAL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY;

EID: 0345466647     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199909)72:1<18::AID-JSO5>3.3.CO;2-G     Document Type: Article

References (30)

1. Blot WJ, Fraumeni JF Jr: Cancers of the lung and pleura. In Schottenfeld D, Fraumeni JF Jr (eds): "Cancer Epidemiology and Prevention." New York: Oxford University Press, 1996:637-665.
2. Woodhouse EC, Chuaqui RF, Liotta LA: General mechanisms of metastasis. Cancer 1997;80:1529-1537.
3. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992; 257:967-971.
4. Liang P, Averboukh L, Pardee AB: Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res 1993;21:3269-3275.
5. Liu Z, Brattain MG, Appert H: Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7. Biochem Biophys Res Commun 1997;231:283-289.
6. Sehgal A, Keener C, Boynton AL, et al.: Characterization of C4-2 as a tumor-suppressor gene in human brain tumors. J Surg Oncol 1997;64:102-108.
7. Musholt TJ, Goodfellow PJ, Scheumann FW, et al.: Differential display in primary and metastatic medullary thyroid carcinoma J Surg Res 1997;69:94-100.
8. Lee JH, Welch DR: Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display. Int J Cancer 1997;71:1035-1044.
9. Duncan LM, Deeds J, Hunter J, et al.: Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res 1998;58:1515-1520.
10. Martín-Satué M, Marrugat R, Cancelas JA, Blanco J: Enhanced expression of alpha(1,3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells. Cancer Res 1998;58:1544-1550.
11. Inufusa H, Kojima N, Yasutomi M, Hakomori S: Human lung adenocarcinoma cell lines with different lung colonization potential (LCP), and a correlation between expression of sialosyl dimeric Le(x) (defined by MAb FH6) and LCP. Clin Exp Metastasis 1991;9:245-257.
12. Martín-Satué M, de Castellarnau C, Blanco J: Overexpression of α(1,3)-fucosyltransferase VII is sufficient for the acquisition of lung colonization phenotype in human lung adenocarcinoma HAL-24Luc cells. Br J Cancer 1999;80(8):1169-1174.
13. Fidler IJ: Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990;50:6130-6138.
14. Dong B, Horowitz DS, Kobayashi R, Krainer AR: Purification and cDNA cloning of HeLa cell p54nrb, a nuclear protein with two RNA recognition motifs and extensive homology to human splicing factor PSF and Drosophila NONA/BJ6. Nucleic Acids Res 1993;21:4085-4092.
15. Harwood CA, Green MA, Cook MG: CD44 expression in melanocytic lesions: a marker of malignant progression?. Br J Dermatol 1996;135:876-882.
16. De Rossi G, Marroni P, Paganuzzi M, et al.: Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemia. Leukemia 1997; 11:134-141.
17. Siebert PD, Huang BC: Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines. Proc Natl Acad Sci USA 1997;94:2198-2203.
18. Sykes DE, Weiser MM: The identification of genes specifically expressed in epithelial cells of the rat intestinal crypts. Differentiation 1992;50:41-46.
19. Dong JT, Isaacs WB, Barrett JC Isaacs JT: Genomic organization of the human KAI1 metastasis-suppressor gene. Genomics 1997; 41:25-32.
20. Kolodkin AL: Semaphorins: mediators of repulsive growth cone guidance. Trends Cell Biol 1996;6:15-22.
21. Kolodkin AL, Matthes DJ, O'Connor TP, et al.: Fasciclin IV: sequence, expression, and function during growth cone guidance in the grasshopper embryo. Neuron 1992;9:831-845.
22. Luo Y, Raible D, Raper JA: Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 1993;75:217-227.
23. Püschel AW, Adams RH, Betz H: Murine semaphorin D/collapsin is a member of a diverse gene family and creates domains inhibitory for axonal extension. Neuron 1995;14:941-948.
24. Matthes DJ, Sink H, Kolodkin AL, Goodman CS: Semaphorin II can function as a selective inhibitor of specific synaptic arborizations. Cell 1995;81:631-639.
25. Bagnard D, Lohrum M, Uziel D et al.: Semaphorins act as attractive and repulsive guidance signals during the development of cortical projections. Development 1998;125:5043-5053.
26. Hall KT, Boumsell L, Schultze JL, et al.: Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci USA 1996;93:11780-11785.
27. Yamada T, Endo R, Gotoh M, Hirohashi S: Identification of semaphorin E as a non-MDR drug resistance gene of human cancers. Proc Natl Acad Sci USA 1997;94:14713-14718.
28. Ray CA, Black RA, Kronheim SR, et al.: Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 1992;69:597-604.
29. Mangasser-Stephan K, Dooley S, Welter C, et al.: Identification of human semaphorin E gene expression in rheumatoid synovial cells by mRNA differential display. Biochem Biophys Res Commun 1997;234:153-156.
30. Seki T, Selby J, Häupl T, Winchester R: Use of a differential subtraction method to identify genes that characterize the phenotype of cultured rheumatoid arthritis synoviocytes. Arthritis Rheum 1998;41:1356-1364.